18 Ankylosing Spondylitis Clinical Trials in Kansas City, MO (2026)

Q: How do I join a clinical trial in Kansas City?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you.

Recruiting Ankylosing Spondylitis Studies in Kansas City

NCT07052942Recruiting

Individualizing Treatment for Asthma in Primary Care (Full Study)

While asthma therapy is becoming more individualized based on asthma phenotypes, more research is needed to tailor newer therapies to individuals. Inhaled corticosteroid (ICS) medications are the foun...

Kansas City, MOPHASE43,200 participantsDARTNet Institute

View Study Details

NCT02302742Recruiting

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

PROGECT is a registry for patients with Triple Negative breast cancer (TNBC) or patients who have an identified germline mutations (such as a mutation on the BRCA1 or BRCA2 genes)....

Kansas City, MO3,000 participantsUniversity of Kansas Medical Center

View Study Details

NCT07069400Recruiting

An International Observational Study of Adults With Acute Infection

Prospective, longitudinal studies of people with acute infections are essential to understand risk factors, clinical manifestations, pathobiology, and management strategies. Observational studies can ...

Kansas City, MO1,500 participantsUniversity of Minnesota

View Study Details

NCT00327860Recruiting

Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)

The Division of Kidney, Urologic, and Hematologic Diseases (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in collaboration with the Eunice Kennedy Shriver Nat...

Kansas City, MO1,300 participantsJohns Hopkins Bloomberg School of Public Health

View Study Details

NCT06517628Recruiting

The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study

This is a prospective, observational study which is evaluating the obstetrical, neonatal, and cardiovascular outcomes of 1000 pregnant people with known heart disease to define how best to structure c...

Kansas City, MO1,000 participantsUniversity of Missouri, Kansas City

View Study Details

NCT06310031Recruiting

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

The goal of this study is to evaluate the safety and efficacy of the BrioVAD System by demonstrating non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of ad...

Kansas City, MONA780 participantsBrioHealth Solutions, Inc.

View Study Details

NCT07143669Recruiting

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

This is a multicenter screening study to characterize the prevalence of the KIT D816V mutation in participants with suspected clonal mast cell disease....

Kansas City, MO750 participantsBlueprint Medicines Corporation

View Study Details

NCT06772493Recruiting

ViewFlex X ICE First-in-Human Study

This prospective, acute, first-in-human, non-significant risk study is intended to evaluate a modified version of the ViewFlex X ICE Catheter, Sensor Enabled (ViewFlex X SE) and ViewMate Multi Ultraso...

Kansas City, MO500 participantsAbbott Medical Devices

View Study Details

NCT03460977Recruiting

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

The purpose of this study is to learn about the safety and effects of the study medicine (called Mevrometostat) for the possible treatment of Relapsed/ Refractory Small Cell Lung Cancer (SCLC), Castra...

Kansas City, MOPHASE1453 participantsPfizer

View Study Details

NCT07043400Recruiting

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

This study is designed to assess the levels of drug exposure following treatment with tislelizumab administered as a subcutaneous (SC) injection compared to intravenous infusion (IV) as first-line the...

Kansas City, MOPHASE3351 participantsBeiGene

View Study Details

NCT07206225Recruiting

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

The purpose of this study is to learn how a new medicine called PF-08052667 works when used by itself or together with another medicine called Bacillus Calmette Guerin (BCG), and/or a medicine called ...

Kansas City, MOPHASE1294 participantsPfizer

View Study Details

NCT04629469Recruiting

Low Field and High Field Magnetic Resonance Imaging Assessments on Pediatric Patients

Hyperfine Research, Inc. has taken advantage of technological advances and developed an MRI device that is not only portable, but also uses a very-low magnetic field strength, \[less than 0.2 Tesla or...

Kansas City, MONA250 participantsChildren's Mercy Hospital Kansas City

View Study Details

NCT07094087Recruiting

Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)

This is a phase 3, multicenter, randomized, open-label, parallel-group, controlled study to assess the efficacy and safety of BE1116 compared with fresh frozen plasma (FFP) in adult participants under...

Kansas City, MOPHASE3200 participantsCSL Behring

View Study Details

NCT07656727Recruiting

A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors

The purpose of this study is to learn about the effects of BGE-102 on blood biomarkers including hsCRP, which is a lab value used to measure inflammation. BGE-102 decreases inflammation which may impr...

Kansas City, MOPHASE2160 participantsBioAge Labs, Inc.

View Study Details

NCT05530408Recruiting

Quantitative Pulmonary Imaging Registry & Biorepository

The goal of this project is to establish a registry and biorepository of images and biological samples from subjects undergoing novel pulmonary imaging methods to be used for future research aimed tow...

Kansas City, MO100 participantsUniversity of Kansas Medical Center

View Study Details

NCT07368998Recruiting

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

The purpose of this study is to evaluate the efficacy and safety of inavolisib in combination with fulvestrant compared with inavolisib in combination with fulvestrant in participants with PIK3CA-muta...

Kansas City, MOPHASE280 participantsHoffmann-La Roche

View Study Details

NCT06965426Recruiting

Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study

To compare skin carotenoid scores over 12 weeks of individuals randomized to placebo or MacuHealth and comparing that to a 12 week crossover evaluation....

Kansas City, MONA60 participantsInsight Eyecare Specialties, Inc. dba Vision Source Eyecare,

View Study Details

NCT06589245Recruiting

Inhaled Ciclesonide Study in Preterm Infants

Our overall objective is to conduct a safety study with inhaled ciclesonide to evaluate known glucocorticoids (sGC)-related acute and intermediate toxic effects while measuring for the first time in n...

Kansas City, MOPHASE130 participantsVenkatesh Sampath

View Study Details

About Ankylosing Spondylitis Clinical Trials in Kansas City

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 18 ankylosing spondylitis clinical trials recruiting participants in Kansas City, MO. These studies are seeking a combined 14,008 participants. Research is being sponsored by DARTNet Institute, University of Kansas Medical Center, University of Minnesota and 13 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Kansas City — FAQ

Are there ankylosing spondylitis clinical trials in Kansas City?

Yes, there are 18 ankylosing spondylitis clinical trials currently recruiting in Kansas City, MO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Kansas City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you about next steps.

Are clinical trials in Kansas City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kansas City studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 18 active trials in Kansas City are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated September 4, 2026 from ClinicalTrials.gov